Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
NCT01367639 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2013-11-25
Summary
Breast cancer (BC) is a major health problem and the most prevalent cancer among women.In a substantial proportion of familial cases, germ-line mutations in either BRCA1/2 can be detected. The only proven modality for active risk reduction (rather than passive early detection), is prophylactic surgery - prophylactic mastectomy and oophorectomy. While the majority of Jewish mutation carriers elect to undergo prophylactic oophorectomy at about age 40 years, in Israel only a minority perform prophylactic mastectomy. Another ramification of being a mutation carrier is the emotional stress associated with that discovery.Genetic information has profound implications for mutation carriers. The IBSR (Inquiry-based stress reduction) intervention, developed by Byron Katie, trains participants to reduce their perceived level of stress by self-inquiry of their thoughts and beliefs connected to stressful circumstances or symptoms. This meditative process, named "The Work", enables the participants to identify and question the stressful thoughts that cause their suffering. The core of IBSR is simply four questions and a turnaround, which is a way of experiencing the opposite of what the participant believes. This process is simple, powerful and provides skills for self-inquiry and management of stressful thoughts that can be easily implemented in daily life \[ \]. Therefore, on the basis of previous data and beneficial observations we postulate that the clinical utility of IBSR mediation program may improve psychological and physical symptoms and quality of life among asymptomatic (oncologically healthy) BRCA1/ BRCA2 mutation carriers. Thus, we will conduct a pilot randomized controlled trial to scientifically investigate the effect of this intervention effects on BRCA1/2 mutation carriers.
Conditions
- Hereditary Breast and Ovarian Cancer Syndrome
Interventions
- BEHAVIORAL
-
Inquiry Based Stress Reduction (IBSR) program
The IBSR (Inquiry-based stress reduction) intervention, developed by Byron Katie, trains participants to reduce their perceived level of stress by self-inquiry of their thoughts and beliefs connected to stressful circumstances or symptoms. This meditative process, named "The Work", enables the participants to identify and question the stressful thoughts that cause their suffering. The core of IBSR is simply four questions and a turnaround, which is a way of experiencing the opposite of what the participant believes. This process is simple, powerful and provides skills for self-inquiry and management of stressful thoughts that can be easily implemented in daily life
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Eitan Friedman, Prof. · Sheba Medical Center
-
Shahar Lev-ari, Dr. · Department of health promotion, faculty of medicine, Tel Aviv University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2011-12-31
- Completion
- 2012-06-30
Countries
- Israel
Study Locations
More Related Trials
-
The Link Between BRCA Mutation and Endothelial Function
NCT02474264 ·Status: UNKNOWN ·Phase: NA
-
Preoperative Breast Irradiation
NCT02941835 ·Status: TERMINATED ·Phase: NA
-
Patient Empowerment by Group Medical Consultations
NCT01329068 ·Status: UNKNOWN ·Phase: NA
-
Breast Cancer Risk Reduction: A Patient Doctor Intervention
NCT01830933 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
NCT00590109 ·Status: COMPLETED
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING
-
CBPR - BRCA Genetic Testing Among Orthodox Jews
NCT03624088 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Risk Assessment in Women Aged 40-49
NCT03180086 ·Status: COMPLETED ·Phase: NA
-
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
NCT05939128 ·Status: ACTIVE_NOT_RECRUITING
-
Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer
NCT02065960 ·Status: UNKNOWN ·Phase: PHASE1
-
Cancer Prevention in Women With a BRCA Mutation
NCT02225015 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer
NCT02833233 ·Status: COMPLETED ·Phase: NA
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.
NCT05318274 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast Cancer
NCT03165006 ·Status: COMPLETED
-
Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations
NCT05264532 ·Status: COMPLETED ·Phase: NA
-
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT00165152 ·Status: COMPLETED ·Phase: NA
-
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes
NCT03396341 ·Status: RECRUITING
-
MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC
NCT07327021 ·Status: RECRUITING ·Phase: PHASE2
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Fluorescence Guided Surgery in Breast Cancer
NCT02583568 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy
NCT06885671 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
NCT03319290 ·Status: UNKNOWN